Cytotoxic drug resistance: molecular basis and clinical significance.
Twentyman
P R
PR
MRC Clinical Oncology and Radiotherapeutics Unit, Cambridge, UK.
Bleehen
N M
NM
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004260:DNA Repair; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004351:Drug Resistance; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins; D004250:DNA Topoisomerases, Type II; D005978:Glutathione